首页>Journal of clinical psychopharmacology>Reboxetine adjuvant therapy in patients with schizophrenia showing a suboptimal response to clozapine: A 12-week, open-label, pilot study
Reboxetine adjuvant therapy in patients with schizophrenia showing a suboptimal response to clozapine: A 12-week, open-label, pilot study
作者单位：Departments of Neurosciences, Policlinico Universitario G. Martino, Via Consolare Valeria 1[1]Department of Health Sciences, University Magna Graecia, Catanzaro, Italy[2]Clinical and Experimental Medicine and Pharmacology, University of Messina, Messina, Italy[3]
换一批
换一批
